You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

glucagon

Showing 1 - 25 of 47
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Type 1 Diabetes Trial in Trondheim (Glucagon)

Recruiting
  • Type 1 Diabetes
  • Glucagon
  • Trondheim, Norway
    Department of Endocrinology, St. Olavs Hospital
Jul 17, 2023

Obesity Trial in Orlando (Glucagon)

Active, not recruiting
  • Obesity
  • Glucagon
  • Orlando, Florida
    Translational Research Institute for Metabolism and Diabetes
Feb 1, 2023

Post-bariatric Hypoglycemia Trial in Boston (glucagon, Closed loop glucagon pump)

Completed
Has Results
  • Post-bariatric Hypoglycemia
  • glucagon
  • Closed loop glucagon pump
  • Boston, Massachusetts
    Joslin Diabetes Center
Aug 7, 2022

Healthy Participants Trial in New Haven (Glucagon)

Active, not recruiting
  • Healthy Participants
  • Glucagon
  • New Haven, Connecticut
    Yale Hospital reserach Unit / YCCI
Jan 17, 2022

Obesity Trial in Orlando (Glucagon, Placebo)

Active, not recruiting
  • Obesity
  • Glucagon
  • Placebo
  • Orlando, Florida
    Translational Research Institute for Metabolism and Diabetes
Oct 5, 2021

Insulin Resistance, Prediabetic State, Non-Alcoholic Fatty Liver Disease Trial in New York (drug, other, dietary supplement,

Not yet recruiting
  • Insulin Resistance
  • +3 more
  • Insulin human
  • +11 more
  • New York, New York
    Columbia University Irving Medical Center
Nov 6, 2023

Type 1 Diabetes, Hypoglycemia Trial in Gentofte (Glucagon, Closed-loop system)

Completed
  • Type 1 Diabetes
  • Hypoglycemia
  • Glucagon
  • Closed-loop system
  • Gentofte, Denmark
    Steno Diabetes Center Copenhagen
Aug 17, 2022

Colon Cancer Trial in San Francisco (Glucagon)

Completed
Has Results
  • Colon Cancer
  • Glucagon
  • San Francisco, California
    San Francisco General Hospital
Mar 24, 2021

Insulin Secretion Trial in Durham (Glucagon)

Completed
  • Insulin Secretion
  • Glucagon
  • Durham, North Carolina
    Duke Center for Living
May 12, 2021

Non-Alcoholic Fatty Liver Disease, Glucagon Resistance Trial in Hellerup (Glucagon)

Recruiting
  • Non-Alcoholic Fatty Liver Disease
  • Glucagon Resistance
  • Glucagon
  • Hellerup, Copenhagen, Denmark
    Center for Clinical Metabolic Research
Apr 27, 2021

Insulin Resistance, Prediabetic State, Hyperinsulinemia Trial in New York (drug, other, dietary supplement, device)

Recruiting
  • Insulin Resistance
  • +4 more
  • Insulin human
  • +8 more
  • New York, New York
    Columbia University Irving Medical Center
Feb 2, 2023

Hypoglycemia Unawareness, Diabetes, Type 1 Trial in United States (Glucagon, Placebo)

Terminated
Has Results
  • Hypoglycemia Unawareness
  • Diabetes Mellitus, Type 1
  • Glucagon
  • Placebo
  • Birmingham, Alabama
  • +4 more
Feb 2, 2021

Type 1 Diabetes Trial in Gentofte, Herlev (Glucagon, Closed-loop System)

Recruiting
  • Type 1 Diabetes
  • Glucagon
  • Closed-loop System
  • Gentofte, Denmark
  • +1 more
Jul 6, 2021

Diabetes, Type 1 Trial in Boston (Insulin Lispro, ZP4207 (dasiglucagon), Glucagon)

Completed
Has Results
  • Diabetes Mellitus, Type 1
  • Insulin Lispro
  • +4 more
  • Boston, Massachusetts
    MGH Diabetes Center
Feb 26, 2021

Type1 Diabetes Trial in Neuss (Insulin glulisine (U300), Insulin glulisine, Insulin aspart)

Completed
  • Type1 Diabetes Mellitus
  • Insulin glulisine (U300)
  • +6 more
  • Neuss, Germany
    Investigational Site Number 276001
Apr 21, 2022

Type1diabetes Trial in Gentofte, Hillerød (drug, procedure, device)

Recruiting
  • Type1diabetes
  • insulin human
  • +8 more
  • Gentofte, Denmark
  • +1 more
Oct 14, 2021

Type 1 Diabetes With Hypoglycemia Trial in Atlanta (Glucagon, Insulin)

Completed
  • Type 1 Diabetes Mellitus With Hypoglycemia
  • Atlanta, Georgia
    Atlanta Diabetes Associates
Jan 14, 2021

Type 1 Diabetes Trial in Boston (Bihormonal Bionic Pancreas, Insulin Only Bionic Pancreas, Glucagon)

Terminated
Has Results
  • Type 1 Diabetes Mellitus
  • Bihormonal Bionic Pancreas
  • +3 more
  • Boston, Massachusetts
    MGH Diabetes Research Center
Nov 26, 2019

Drug Overdose, Overdose of Beta-adrenergic Blocking Drug Trial in Copenhagen (Glucagon, Esmolol, Physiologic saline - glucagon

Completed
  • Drug Overdose
  • Overdose of Beta-adrenergic Blocking Drug
  • Glucagon
  • +3 more
  • Copenhagen, Denmark
    University Hospital Bispebjerg
Oct 16, 2019

Healthy Trial in Mount-Royal (Nasal Glucagon, Glucagon)

Completed
Has Results
  • Healthy
  • Nasal Glucagon
  • Glucagon
  • Mount-Royal, Quebec, Canada
    For additional information regarding investigative sites for thi
Aug 14, 2019

Non-Alcoholic Fatty Liver Disease, Total Pancreatectomy, Diabetes Trial in Hellerup (Glucagon, Saline)

Completed
  • Non-Alcoholic Fatty Liver Disease
  • +2 more
  • Hellerup, Denmark
    Center for Clinical Metabolic Research, Gentofte Hospital, Unive
Aug 5, 2019

Diabetes, Type 1 Trial in United States (Glucagon)

Completed
Has Results
  • Diabetes Mellitus, Type 1
  • Glucagon
  • Stanford, California
  • +6 more
Nov 16, 2018

Type 1 Diabetes Trial (other, device, drug)

Withdrawn
  • Type 1 Diabetes
  • 15-week intervention with sensor-augmented pump
  • +6 more
  • (no location specified)
Jul 22, 2019

Obesity Trial in Toronto (Glucagon, Placebo)

Unknown status
  • Obesity
  • Glucagon
  • Placebo
  • Toronto, Ontario, Canada
    Toronto General Hospital
Aug 28, 2018

Diabetes, Diabetes, Type 1, Diabetes, Type 2 Trial in Berlin (NNC9204-1513, Glucagon, Placebo)

Completed
  • Diabetes
  • +2 more
  • Berlin, Germany
    Novo Nordisk Investigational Site
Sep 3, 2018